Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
1 clinical trials · Condition
◉ Watch Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers (NCT00861965) | Mirror Biologics, Inc. | 2010-01-01 |
Track Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.